Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
Clinical trial NCT04846868 · COMPLETED
Trial details
- NCT number
- NCT04846868
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2024-09-17
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.